GlassScriptPhysician profile
Alexander Munchiando
NPI 1174048219
$3,909.65
in general payments reported to CMS, 2019-2025
32 companies · $239 in 2025
The $239 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $805 · 2022: $1,225 · 2023: $1,174 · 2024: $467 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,763 · Education: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,762.76 |
| Education | $117.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $711.63 | 2021-2024 | Myrbetriq, Xtandi, Veozah |
| Axonics, INC. | $536.89 | 2021-2023 | Axonics |
| Pfizer INC. | $319.89 | 2021-2025 | |
| Procept Biorobotics Corporation | $257.87 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Sumitomo Pharma America, INC. | $215.97 | 2023-2024 | Orgovyx, Gemtesa |
| Clarus Therapeutics INC. | $202.41 | 2021 | |
| Myovant Sciences INC. | $170.11 | 2022 | |
| Urogen Pharma, INC. | $148.17 | 2022-2024 | Jelmyto |
| Medtronic, INC. | $138.45 | 2023 | Interstim |
| Myriad Genetic Laboratories, INC. | $124.01 | 2021-2023 | Prolaris |
| 180 Medical, INC. | $118.48 | 2021-2024 | Cure Catheter |
| Endo Pharmaceuticals INC. | $111.10 | 2021-2023 | Xiaflex |
| Bayer Healthcare Pharmaceuticals INC. | $107.99 | 2021-2023 | |
| Abbvie INC. | $103.92 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $90.70 | 2022-2023 | Lynparza, Keytruda |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $87.59 | 2022-2023 | Yonsa |
| Antares Pharma, INC. | $80.95 | 2022-2023 | Tlando, Nocdurna, Xyosted |
| Blue Earth Diagnostics | $62.94 | 2021 | |
| Allergan, INC. | $45.28 | 2021 | |
| Urovant Sciences INC | $35.77 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $29.89 | 2024 | Pipeline, Erleada |
| Tolmar, INC. | $27.97 | 2024 | |
| Calyxo, INC. | $24.09 | 2024 | Cvac Aspiration System |
| Progenics Pharmaceuticals, INC. | $21.66 | 2024 | |
| Novartis Pharmaceuticals Corporation | $20.43 | 2024 | |
| Convatec INC. | $19.14 | 2021 | |
| Photocure INC | $17.82 | 2023 | Cysview |
| Janssen Biotech, INC. | $17.80 | 2021 | |
| Coloplast Corp | $17.57 | 2023 | Speedicath |
| Dentsply Ih INC. | $15.84 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $13.81 | 2022 | |
| Laborie Medical Technologies Corp. | $13.51 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Munchiando listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.